Recombinant Influenza Vaccine Found to Be Safe in Children

MONDAY, April 2, 2018 -- The recombinant influenza vaccine (RIV4) is well tolerated in children aged 6 to 17 years, and it provides immunogenicity comparable to that of the inactivated vaccine, according to a study published online April 2 in...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news